Literature DB >> 32789204

Inpatient Multidisciplinary Rehabilitation Intervention Outcomes for Neuromyelitis Optica Spectrum Disorder: A Retrospective Observational Study.

Junko Ikeda1, Yumiko Kaseda1, Takanori Namba2, Mitsuhiro Ochi3, Miwa Hayata4, Tatsuo Kohriyama1.   

Abstract

OBJECTIVE: Neuromyelitis optica spectrum disorders (NMOSD) are immune-mediated chronic inflammatory disorders of the central nervous system that are predominantly characterized by attacks of optic neuritis and/or transverse myelitis. The aim of this study was to investigate the clinical rehabilitation course of patients with NMOSD.
METHODS: We carried out a retrospective evaluation of 20 cases of NMOSD in which the patients underwent multidisciplinary inpatient rehabilitation intervention starting within 2 months after acute exacerbation. Rehabilitation outcomes were assessed using the modified Rankin Scale, the Expanded Disability Status Scale (EDSS), and the Functional Independence Measure (FIM).
RESULTS: A total of 19 cases were finally included in this study. The average EDSS scores ranged from 5.9 to 7.1 during hospitalization. Lower age significantly correlated with improved EDSS scores. Changes in the EDSS score during rehabilitation varied in patients experiencing their first attack; however, improvements in the EDSS score of ≥ 1.5 were observed only in patients who had experienced two or less attacks. During rehabilitation, the FIM significantly improved from 81.4 to 101.7, with a gain of 20.3 and efficacy of 0.2/day.
CONCLUSION: Multidisciplinary rehabilitation may improve functional recovery after NMOSD attacks. Younger age and two or less attacks were associated with better outcomes in this study. ©2016 The Japanese Association of Rehabilitation Medicine.

Entities:  

Keywords:  multidisciplinary; neuromyelitis optica spectrum disorders; outcome; rehabilitation

Year:  2016        PMID: 32789204      PMCID: PMC7365197          DOI: 10.2490/prm.20160007

Source DB:  PubMed          Journal:  Prog Rehabil Med        ISSN: 2432-1354


  14 in total

1.  Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study.

Authors:  M Nakamura; I Miyazawa; K Fujihara; I Nakashima; T Misu; S Watanabe; T Takahashi; Y Itoyama
Journal:  J Neurol       Date:  2008-02-04       Impact factor: 4.849

Review 2.  Neuromyelitis optica (Devic's syndrome).

Authors:  Dean M Wingerchuk; Brian G Weinshenker
Journal:  Handb Clin Neurol       Date:  2014

3.  Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.

Authors:  T Misu; K Fujihara; A Kakita; H Konno; M Nakamura; S Watanabe; T Takahashi; I Nakashima; H Takahashi; Y Itoyama
Journal:  Brain       Date:  2007-04-02       Impact factor: 13.501

4.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Authors:  Vanda A Lennon; Dean M Wingerchuk; Thomas J Kryzer; Sean J Pittock; Claudia F Lucchinetti; Kazuo Fujihara; Ichiro Nakashima; Brian G Weinshenker
Journal:  Lancet       Date:  2004 Dec 11-17       Impact factor: 79.321

5.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

6.  Rehabilitation of neuromyelitis optica (Devic syndrome): three case reports.

Authors:  Adam L Schreiber; Guy W Fried; Christopher S Formal; Bryan X DeSouza
Journal:  Am J Phys Med Rehabil       Date:  2008-02       Impact factor: 2.159

7.  Effectiveness of multi-disciplinary rehabilitation for patients with Neuromyelitis Optica.

Authors:  Yael Nechemia; Elior Moreh; Harold Weingarden; Ayala Bloch; Uri Givon; Adi Vaknin-Dembinsky; Isabella Schwartz; Zeev Meiner; Gabi Zeilig
Journal:  J Spinal Cord Med       Date:  2016-03-24       Impact factor: 1.985

8.  Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.

Authors:  Joanna Kitley; M Isabel Leite; Ichiro Nakashima; Patrick Waters; Benjamin McNeillis; Rachel Brown; Yoshiki Takai; Toshiyuki Takahashi; Tatsuro Misu; Liene Elsone; Mark Woodhall; Jithin George; Mike Boggild; Angela Vincent; Anu Jacob; Kazuo Fujihara; Jacqueline Palace
Journal:  Brain       Date:  2012-05-09       Impact factor: 13.501

9.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

Review 10.  Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).

Authors:  Corinna Trebst; Sven Jarius; Achim Berthele; Friedemann Paul; Sven Schippling; Brigitte Wildemann; Nadja Borisow; Ingo Kleiter; Orhan Aktas; Tania Kümpfel
Journal:  J Neurol       Date:  2013-11-23       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.